Data / Form D filings / Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc.: Form D filings
Calidi Biotherapeutics, Inc., a biotechnology company in San Diego, CA, filed 6 Form D notices with the SEC in 2024. The latest, on June 6, 2024, reports $5.5 million sold of a $5.5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4475 EXECUTIVE DRIVE, SUITE 200, San Diego, CA, 92121
- Phone
- (858) 794-9600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1855485
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2024 | New notice | $5,549,588 | $5,549,588 | 9 | Jun 3, 2024 | sec.gov | |
| Mar 21, 2024 | New notice | $65,000 | $32,500 | $32,500 | 1 | Feb 21, 2024 | sec.gov |
| Mar 21, 2024 | New notice | $3,500,000 | $3,500,000 | 1 | Mar 8, 2024 | sec.gov | |
| Mar 21, 2024 | New notice | $341,250 | $195,000 | $146,250 | 1 | Nov 1, 2023 | sec.gov |
| Mar 21, 2024 | New notice | $10,000 | $10,000 | 1 | Jan 19, 2024 | sec.gov | |
| Mar 21, 2024 | New notice | $1,000,000 | $1,000,000 | 1 | Jan 26, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James A. Schoeneck | Director | |
| George R. Ng | Director | |
| Boris Minev | Executive Officer | |
| Scott R. Leftwich | Director | |
| Wendy Pizarro | Executive Officer | |
| Alan R. Stewart | Director | |
| Andrew Jackson | Executive Officer | |
| Allan Camaisa | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 3, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Calidi Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.